Pages that link to "Q53627639"
Jump to navigation
Jump to search
The following pages link to Radiotherapy for local control of osteosarcoma. (Q53627639):
Displaying 50 items.
- Spinal osteosarcoma (Q26996533) (← links)
- Review of Osteosarcoma and Current Management (Q28077590) (← links)
- Osteosarcoma in Korean children and adolescents (Q28083794) (← links)
- Multidisciplinary management of primary tumors of the vertebral column (Q33273430) (← links)
- Assessment of the Extent of Surgical Resection as a Predictor of Survival in Patients With Primary Osseous Spinal Neoplasms (Q33274232) (← links)
- Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database (Q33274663) (← links)
- Osteosarcoma Overview (Q33725511) (← links)
- Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma (Q33785368) (← links)
- WEE1 inhibition sensitizes osteosarcoma to radiotherapy (Q33884881) (← links)
- Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma (Q33966580) (← links)
- Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line (Q34220071) (← links)
- Current status of radiotherapy with proton and light ion beams (Q34576474) (← links)
- Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223. (Q34662423) (← links)
- Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma (Q34762699) (← links)
- Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group (Q36013283) (← links)
- Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment. (Q36180744) (← links)
- Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. (Q36277346) (← links)
- Chemotherapy resistance in osteosarcoma: current challenges and future directions. (Q36532115) (← links)
- Management of osteosarcoma (Q36619766) (← links)
- Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives (Q36623353) (← links)
- Novel therapeutic approaches in pediatric and young adult sarcomas (Q36718644) (← links)
- Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies. (Q36731426) (← links)
- Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma (Q37026245) (← links)
- Advanced-technology radiation therapy for bone sarcomas (Q37038348) (← links)
- Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents (Q37038352) (← links)
- Bone tumors in adolescents and young adults (Q37152000) (← links)
- Current concepts on the surgical and medical management of osteosarcoma. (Q37242673) (← links)
- Therapy for osteosarcoma: where do we go from here? (Q37255178) (← links)
- The multidisciplinary management of osteosarcoma (Q37400016) (← links)
- Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma (Q37688626) (← links)
- Proton radiotherapy for pediatric sarcoma (Q37693473) (← links)
- Pediatric sarcomas and related tumors of the head and neck (Q37877009) (← links)
- Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE. (Q38058168) (← links)
- Extraskeletal osteosarcoma of the orbit: A clinicopathologic case report and review of literature (Q38095714) (← links)
- Current therapeutic strategies and novel approaches in osteosarcoma (Q38161735) (← links)
- State-of-the-art approach for bone sarcomas. (Q38208930) (← links)
- Significance of MTA1 in the molecular characterization of osteosarcoma (Q38260257) (← links)
- Inhibiting DNA-PKCS radiosensitizes human osteosarcoma cells (Q38712083) (← links)
- Drugs in early clinical development for the treatment of osteosarcoma (Q38955517) (← links)
- Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine (Q39179763) (← links)
- Current update on the diagnosis and management of head and neck hard tissue sarcomas. (Q39197993) (← links)
- IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines. (Q39490067) (← links)
- Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma (Q40191105) (← links)
- Effect of low- and high-linear energy transfer radiation on in vitro and orthotopic in vivo models of osteosarcoma by activation of caspase-3 and -9 (Q41390604) (← links)
- Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells (Q41843755) (← links)
- Unusual cause of neuropathy: extensive dural spread of primary cervical osteosarcoma (Q42546617) (← links)
- Non surgical treatment of sacral osteosarcoma (Q43179431) (← links)
- Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma (Q44582217) (← links)
- Multimodality treatment of osteosarcoma: radiation in a high-risk cohort (Q46795909) (← links)
- Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma. (Q48256592) (← links)